A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: A study of the PMH phase II consortium

Natasha B. Leighl, Scott A. Laurie, Xueyu E. Chen, Peter Ellis, Frances A. Shepherd, Jennifer J. Knox, Glenwood Goss, Ronald L. Burkes, Gregory R. Pond, Christopher Dick, Yun Yen, James A. Zwiebel, Malcolm J. Moore

研究成果: 雜誌貢獻文章同行評審

15 引文 斯高帕斯(Scopus)

指紋

深入研究「A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: A study of the PMH phase II consortium」主題。共同形成了獨特的指紋。

Medicine & Life Sciences